BCPC - Company ID 0000009326
The table below shows BALCHEM CORP's income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|---|
| Revenue | $290.66M | $284.00M | $270.71M | $263.62M | $267.56M | $255.47M |
| Cost of revenue | $184.94M | $180.31M | $169.63M | - | $172.10M | $162.35M |
| Gross profit | $105.71M | $103.68M | $101.08M | $93.90M | $95.45M | $93.11M |
| R&D | $5.34M | $4.53M | $5.88M | - | $4.50M | $4.30M |
BALCHEM CORP reported annual revenue of $1.04B for fiscal year 2025. That is up 8.8% from $953.68M in fiscal 2024. Over the 10 fiscal years shown, annual revenue grew from $553.20M (FY 2016) to $1.04B. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| SG&A | $17.24M | $18.79M | $18.48M | - | $17.29M | $18.07M |
| Operating income | $62.44M | $59.22M | $55.63M | - | $54.58M | $51.44M |
| Income tax | $13.32M | $13.17M | $12.24M | - | $11.76M | $10.73M |
| Net income | $46.73M | $44.62M | $40.28M | $39.23M | $40.29M | $38.28M |
| EPS (diluted) | $1.46 | $1.39 | $1.25 | $1.21 | $1.24 | $1.17 |